Literature DB >> 23111889

Can we trust in trials stopped early for benefit?

Giovanni Casazza1, Francesco Casella.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 23111889     DOI： 10.1007/s11739-012-0871-0

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  7 in total

1.  When to stop a clinical trial.

Authors:  S J Pocock
Journal:  BMJ       Date:  1992-07-25

Review 2.  Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta-regression analysis.

Authors:  Dirk Bassler; Matthias Briel; Victor M Montori; Melanie Lane; Paul Glasziou; Qi Zhou; Diane Heels-Ansdell; Stephen D Walter; Gordon H Guyatt; David N Flynn; Mohamed B Elamin; Mohammad Hassan Murad; Nisrin O Abu Elnour; Julianna F Lampropulos; Amit Sood; Rebecca J Mullan; Patricia J Erwin; Clare R Bankhead; Rafael Perera; Carolina Ruiz Culebro; John J You; Sohail M Mulla; Jagdeep Kaur; Kara A Nerenberg; Holger Schünemann; Deborah J Cook; Kristina Lutz; Christine M Ribic; Noah Vale; German Malaga; Elie A Akl; Ignacio Ferreira-Gonzalez; Pablo Alonso-Coello; Gerard Urrutia; Regina Kunz; Heiner C Bucher; Alain J Nordmann; Heike Raatz; Suzana Alves da Silva; Fabio Tuche; Brigitte Strahm; Benjamin Djulbegovic; Neill K J Adhikari; Edward J Mills; Femida Gwadry-Sridhar; Haresh Kirpalani; Heloisa P Soares; Paul J Karanicolas; Karen E A Burns; Per Olav Vandvik; Fernando Coto-Yglesias; Pedro Paulo M Chrispim; Tim Ramsay
Journal:  JAMA       Date:  2010-03-24       Impact factor: 56.272

Review 3.  Randomized trials stopped early for benefit: a systematic review.

Authors:  Victor M Montori; P J Devereaux; Neill K J Adhikari; Karen E A Burns; Christoph H Eggert; Matthias Briel; Christina Lacchetti; Teresa W Leung; Elizabeth Darling; Dianne M Bryant; Heiner C Bucher; Holger J Schünemann; Maureen O Meade; Deborah J Cook; Patricia J Erwin; Amit Sood; Richa Sood; Benjamin Lo; Carly A Thompson; Qi Zhou; Edward Mills; Gordon H Guyatt
Journal:  JAMA       Date:  2005-11-02       Impact factor: 56.272

4.  Multiplicity in randomised trials II: subgroup and interim analyses.

Authors:  Kenneth F Schulz; David A Grimes
Journal:  Lancet       Date:  2005 May 7-13       Impact factor: 79.321

5.  Ethical issues in stopping randomized trials early because of apparent benefit.

Authors:  Paul S Mueller; Victor M Montori; Dirk Bassler; Barbara A Koenig; Gordon H Guyatt
Journal:  Ann Intern Med       Date:  2007-06-19       Impact factor: 25.391

6.  Stopping or reporting early for positive results in randomized clinical trials: the National Cancer Institute Cooperative Group experience from 1990 to 2005.

Authors:  Edward L Korn; Boris Freidlin; Margaret Mooney
Journal:  J Clin Oncol       Date:  2009-02-23       Impact factor: 44.544

7.  A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis.

Authors:  B Joseph Elmunzer; James M Scheiman; Glen A Lehman; Amitabh Chak; Patrick Mosler; Peter D R Higgins; Rodney A Hayward; Joseph Romagnuolo; Grace H Elta; Stuart Sherman; Akbar K Waljee; Aparna Repaka; Matthew R Atkinson; Gregory A Cote; Richard S Kwon; Lee McHenry; Cyrus R Piraka; Erik J Wamsteker; James L Watkins; Sheryl J Korsnes; Suzette E Schmidt; Sarah M Turner; Sylvia Nicholson; Evan L Fogel
Journal:  N Engl J Med       Date:  2012-04-12       Impact factor: 91.245
  7 in total
  1 in total

1.  Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma.

Authors:  R Golfieri; E Giampalma; M Renzulli; R Cioni; I Bargellini; C Bartolozzi; A D Breatta; G Gandini; R Nani; D Gasparini; A Cucchetti; L Bolondi; F Trevisani
Journal:  Br J Cancer       Date:  2014-06-17       Impact factor: 7.640
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.